These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8647281)

  • 1. Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3.
    Takahashi S; Oida K; Ookubo M; Suzuki J; Kohno M; Murase T; Yamamoto T; Nakai T
    FEBS Lett; 1996 May; 386(2-3):197-200. PubMed ID: 8647281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
    Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
    Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
    J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.
    Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR
    Am J Physiol; 1999 Mar; 276(3):E553-7. PubMed ID: 10070023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS; Fazio S; Mahley RW
    J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
    J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center.
    Salinelli S; Lo JY; Mims MP; Zsigmond E; Smith LC; Chan L
    J Biol Chem; 1996 Sep; 271(36):21906-13. PubMed ID: 8702993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.
    Weisgraber KH; Mahley RW; Kowal RC; Herz J; Goldstein JL; Brown MS
    J Biol Chem; 1990 Dec; 265(36):22453-9. PubMed ID: 2266137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.
    Bohnet K; Pillot T; Visvikis S; Sabolovic N; Siest G
    J Lipid Res; 1996 Jun; 37(6):1316-24. PubMed ID: 8808766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS; Fazio S; Lee YL; Mahley RW
    J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits.
    Wernette-Hammond ME; Garcia Z; Arnold KS; Innerarity TL
    Arteriosclerosis; 1989; 9(4):501-10. PubMed ID: 2546526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
    März W; Hoffmann MM; Scharnagl H; Fisher E; Chen M; Nauck M; Feussner G; Wieland H
    J Lipid Res; 1998 Mar; 39(3):658-69. PubMed ID: 9548597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro.
    Taira K; Bujo H; Hirayama S; Yamazaki H; Kanaki T; Takahashi K; Ishii I; Miida T; Schneider WJ; Saito Y
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1501-6. PubMed ID: 11557679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.
    Ji ZS; Pitas RE; Mahley RW
    J Biol Chem; 1998 May; 273(22):13452-60. PubMed ID: 9593678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective hepatic lipoprotein receptor binding of beta-very low density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E.
    Hui DY; Innerarity TL; Mahley RW
    J Biol Chem; 1984 Jan; 259(2):860-9. PubMed ID: 6319389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.